We only have this paper's title and publication details.
Read it at the sourceHigh-risk population-based breast cancer screening is cost-effective compared with no screening.
No takes yet. Share an insight, caveat, or question.
Sun et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: